AHA 2021: Late-breaking Science Video Collection

  • Published:  12 November 2021

  • Likes: 

    Heart Icon

    3

Up Next

AHA 2021: Late-breaking Science Video Collection

  • Published:  12 November 2021

  • Likes: 

    Heart Icon

    3

Average (ratings)
No ratings
Your rating
Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021. 

For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators. 

Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Late-breaker Discussion Series

3 sessions
AHA 2021 Late-breaker Discussion: The EMPULSE Trial Watch now
AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial Watch now
AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study Watch now

Part 2

View from the Thoraxcenter: Preview of the Late-Breaking Trials

1 session
View from the Thoraxcenter – What's Hot at AHA 2021 Watch now

Part 3

Expert Interviews

11 sessions
Population Strategies for the Management of Hypertension Watch now
ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins Watch now
AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism Watch now
EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns Watch now
EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp Watch now
AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery Watch now
SGLT2 is Associated with Reduction in Atrial-Arrythmic Events Watch now
SMART-CRT: Effects of AV Optimization on CRT Outcomes Watch now
AVATAR: Aortic Valve Replacement Vs Watchful Waiting in Asymptomatic Severe AS Watch now
EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic HF patients Watch now
SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM Watch now

Faculty Biographies

Jeffrey Weitz

Jeffrey Weitz

Professor of Medicine and Biochemistry and Biomedical Sciences & Executive Director

Prof Jeffrey I Weitz is Professor of Medicine and Biochemistry and Biomedical Sciences at McMaster University and Executive Director of the Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton, CA.

He is Past President of the International Society on Thrombosis and Haemostasis and board certified in internal medicine, haematology and medical oncology. Dr Weitz specialises in the care of patients with thrombotic disorders.

His internationally recognised research spans the biochemistry of blood coagulation and fibrinolysis, preclinical thrombosis models and clinical trials of antithrombotic therapies. He has authored over 650 publications across journals such as Blood, Circulation, Lancet, New England Journal of Medicine, Journal of Clinical Investigation and Annals of Internal Medicine, as well as 76 book chapters.

Prof Weitz is an Officer of the Order of Canada and a Fellow of the…

View full profile